Organization: Health Canada
Year: 2024
Month: February
Request Number: A-2023-000820
Request Summary: With respect to the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review on August 2017, copies of any Notice of Deficiency (NOD); a Notice of Non-Compliance (NON); a NOD-Withdrawal (NOD-W), a NON-Withdrawal (NON-W) or sponsor’s letter requesting cancellation of their submission, dated after July 2019.
Disposition: Disclosed in part
Number of pages: 9